Targeting Mitochondria for Therapy of Cardiovascular Disease

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Modulation of Oxidative Stress in Heart Disease

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/978-981-13-8946-7_28
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Nicorandil

  2024cited by this paper
• Mitochondrial diseases.

  2018cited by this paper
• Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association

  2017cited by this paper
• Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015

  2017cited by this paper
• Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.

  2016cited by this paper
• Coenzyme Q10 and Heart Failure: A State-of-the-Art Review

  2016cited by this paper
• Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

  2015cited by this paper
• Mitochondrial pyruvate transport: a historical perspective and future research directions.

  2015cited by this paper
• Use of mesenchymal stem cells for therapy of cardiac disease.

  2015cited by this paper
• Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure: Analysis of Recurrent Cardiovascular Events and Mortality

  2014cited by this paper
• The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.

  2014cited by this paper
• Mitochondrial dynamics in the adult cardiomyocytes: which roles for a highly specialized cell?

  2013cited by this paper
• Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells.

  2012cited by this paper
• Autologous Mesenchymal Stem Cells Mobilize cKit+ and CD133+ Bone Marrow Progenitor Cells and Improve Regional Function in Hibernating Myocardium

  2011cited by this paper
• Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair.

  2011cited by this paper
• Mitochondrial dysfunction in diabetic cardiomyopathy.

  2011cited by this paper
• Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure

  2011cited by this paper
• Cardiac AAV9-S100A1 Gene Therapy Rescues Post-Ischemic Heart Failure in a Preclinical Large Animal Model

  2011cited by this paper
• The Sublime Engine: A Biography of the Human Heart

  2011cited by this paper
• Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure.

  2010cited by this paper
• Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation

  2010cited by this paper
• Mitochondrial genetic diseases

  2010cited by this paper
• Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).

  2010cited by this paper
• An overview of beta-oxidation disorders.

  2009cited by this paper
• Glutathione Deficiency in Cardiac Patients Is Related to the Functional Status and Structural Cardiac Abnormalities

  2009cited by this paper
• Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

  2009cited by this paper
• Endothelial dysfunction in heart failure.

  2008cited by this paper
• VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.

  2008cited by this paper
• Mitochondrial oxidative stress and dysfunction in myocardial remodelling.

  2008cited by this paper
• The failing heart--an engine out of fuel.

  2007cited by this paper
• Perhexiline.

  2007cited by this paper
• Bone marrow stem cell therapy for myocardial angiogenesis.

  2007cited by this paper
• Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.

  2006cited by this paper
• Physiological diversity of mitochondrial oxidative phosphorylation.

  2006cited by this paper
• Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

  2005cited by this paper
• Genomic alterations in cultured human embryonic stem cells

  2005cited by this paper
• Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

  2005cited by this paper
• Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction.

  2005cited by this paper
• Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

  2005cited by this paper
• Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease.

  2004cited by this paper
• Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells

  2004cited by this paper
• Mitochondrial Encephalomyopathies: Therapeutic Approach

  2004cited by this paper
• The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.

  2004cited by this paper
• Cardiac Preconditioning by Volatile Anesthetic Agents: A Defining Role for Altered Mitochondrial Bioenergetics

  2004cited by this paper
• Vitamins, Supplements, Herbal Medicines, and Arrhythmias

  2004cited by this paper
• [How to use the paradigm of ischemic preconditioning to protect the heart?].

  2004cited by this paper
• Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection.

  2004cited by this paper
• Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury*

  2004cited by this paper
• Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n‐3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

  2004cited by this paper
• Statins and myocardial hypertrophy.

  2004cited by this paper
• Oxidatively damaged proteins of heart mitochondrial electron transport complexes.

  2004cited by this paper
• Comment utiliser le paradigme de préconditionnement ischémique pour protéger le myocarde

  2004cited by this paper
• Intracellular calcium increasing at the beginning of reperfusion assists the early recovery of myocardial contractility after diltiazem cardioplegia.

  2003cited by this paper
• Adult cardiac stem cells are multipotent and support myocardial regeneration.

  2003cited by this paper
• Preconditioning by Sevoflurane Decreases Biochemical Markers for Myocardial and Renal Dysfunction in Coronary Artery Bypass Graft Surgery: A Double-blinded, Placebo-controlled, Multicenter Study

  2003cited by this paper
• Strategic advantages of insulin‐like growth factor‐I expression for cardioprotection

  2003cited by this paper
• Delivery of bioactive molecules to mitochondria in vivo

  2003cited by this paper
• Friedreich's Ataxia: Disease mechanisms, antioxidant and Coenzyme Q10 therapy

  2003cited by this paper
• Production of Reactive Oxygen Species by Mitochondria

  2003cited by this paper
• Effects of CCCP-induced mitochondrial uncoupling and cyclosporin A on cell volume, cell injury and preconditioning protection of isolated rabbit cardiomyocytes.

  2003cited by this paper
• DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells.

  2003cited by this paper
• Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.

  2003cited by this paper
• The pyruvate dehydrogenase complex as a target for gene therapy.

  2003cited by this paper
• Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract.

  2003cited by this paper
• Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid.

  2003cited by this paper
• Anti‐oxidative properties of beta‐blockers and angiotensin‐converting enzyme inhibitors in congestive heart failure

  2003cited by this paper
• Growth Factor Signaling for Cardioprotection Against Oxidative Stress-Induced Apoptosis

  2003cited by this paper
• Uncoupling Protein-2 Overexpression Inhibits Mitochondrial Death Pathway in Cardiomyocytes

  2003cited by this paper
• Induction of metallothionein by zinc protects from daunorubicin toxicity in rats.

  2002cited by this paper
• Viral Gene Transfer of the Antiapoptotic Factor Bcl-2 Protects Against Chronic Postischemic Heart Failure

  2002cited by this paper
• Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.

  2002cited by this paper
• Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage.

  2002cited by this paper
• Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart*

  2002cited by this paper
• Protection From AMP 579 Can Be Added to That From Either Cariporide or Ischemic Preconditioning in Ischemic Rabbit Heart

  2002cited by this paper
• Defining gene transfer before expecting gene therapy: putting the horse before the cart.

  2002cited by this paper
• The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure

  2002cited by this paper
• Gene Therapy Strategy for Long-Term Myocardial Protection Using Adeno-Associated Virus-Mediated Delivery of Heme Oxygenase Gene

  2002cited by this paper
• Absence of expression from RNA internalised into electroporated mammalian mitochondria

  2001cited by this paper
• Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease.

  2001cited by this paper
• Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone

  2001cited by this paper
• Base excision repair of mitochondrial DNA damage in mammalian cells.

  2001cited by this paper
• Molecular enzymology of carnitine transfer and transport.

  2001cited by this paper
• Reactive oxygen species generated from the mitochondrial electron transport chain induce cytochrome c dissociation from beef‐heart submitochondrial particles via cardiolipin peroxidation. Possible role in the apoptosis

  2001cited by this paper
• Fatty acid transport

  2001cited by this paper
• Blocking Caspase-Activated Apoptosis Improves Contractility in Failing Myocardium

  2001cited by this paper
• Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling

  2001cited by this paper
• Somatic gene therapy in the cardiovascular system.

  2001cited by this paper
• Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.

  2001cited by this paper
• Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.

  2001cited by this paper
• Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy.

  2001cited by this paper
• Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection.

  2000cited by this paper
• The Human Nm23/Nucleoside Diphosphate Kinases

  2000cited by this paper
• Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical.

  2000cited by this paper
• Localization of the Site of Oxygen Radical Generation inside the Complex I of Heart and Nonsynaptic Brain Mammalian Mitochondria

  2000cited by this paper
• The Contribution of Mitochondrial Respiratory Complexes to the Production of Reactive Oxygen Species

  2000cited by this paper
• Transcriptional modulators targeted at fuel metabolism of hypertrophied heart.

  1999cited by this paper
• Peptide nucleic acid delivery to human mitochondria

  1999cited by this paper
• The antioxidant function of metallothionein in the heart.

  1999cited by this paper
• Calcium Antagonists in the Post-Myocardial Infarction Setting

  1999cited by this paper
• Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.

  1998cited by this paper

• No citing papers are available for this paper.